Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -179.99% is 19% above its 5-year average of -222.27%, around the middle of its 5-year range (-507.12%–-32.20%).
As of the fiscal period ended Tuesday, June 30, 2026. 43.35% above its 12-month average of -317.74%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -179.99%.
RETURN ON EQUITY (ROE)
-179.99%
RETURN ON EQUITY (ROE) AVG TTM
-317.74%
RETURN ON EQUITY (ROE) AVG 3Y
-232.53%
RETURN ON EQUITY (ROE) AVG 5Y
-222.27%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+43.35%
CURRENT VS 3Y AVG
+22.59%
CURRENT VS 5Y AVG
+19.02%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-38.25%
median of 440 covered companies
CURRENT VS SECTOR MEDIAN
-370.57%
vs the sector median at left
Establishment Labs Holdings Inc.
Market Cap
$1.96B
Return on Equity (ROE)
-179.99%
TTM Avg
-317.74%
3Y Avg
-232.53%
5Y Avg
-222.27%
Market Cap
$1.95B
Return on Equity (ROE)
-49.19%
TTM Avg
-59.18%
3Y Avg
-54.84%
5Y Avg
-44.72%
Market Cap
$1.97B
Return on Equity (ROE)
-8.14%
TTM Avg
-6.28%
3Y Avg
-6.47%
5Y Avg
-2.03%
Market Cap
$2.00B
Return on Equity (ROE)
-13.09%
TTM Avg
-10.89%
3Y Avg
-18.29%
5Y Avg
-19.41%
Market Cap
$2.01B
Return on Equity (ROE)
-16.25%
TTM Avg
-99.56%
3Y Avg
-48.75%
5Y Avg
-32.00%
Market Cap
$2.02B
Return on Equity (ROE)
51.09%
TTM Avg
25.46%
3Y Avg
0.90%
5Y Avg
-9.89%
Market Cap
$2.02B
Return on Equity (ROE)
-48.43%
TTM Avg
-97.59%
3Y Avg
-126.46%
5Y Avg
-100.04%
Market Cap
$1.89B
Return on Equity (ROE)
12.01%
TTM Avg
-4.52%
3Y Avg
-16.89%
5Y Avg
-11.36%
Market Cap
$2.05B
Return on Equity (ROE)
16.36%
TTM Avg
13.19%
3Y Avg
3.41%
5Y Avg
-4.94%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Establishment Labs Holdings Inc. (ESTA) | $1.96B | -179.99% | -317.74% | -232.53% | -222.27% |
| Absci Corporation (ABSI)vs › | $1.95B | -49.19% | -59.18% | -54.84% | -44.72% |
| Azenta, Inc. (AZTA)vs › | $1.97B | -8.14% | -6.28% | -6.47% | -2.03% |
| AxoGen, Inc. (AXGN)vs › | $2.00B | -13.09% | -10.89% | -18.29% | -19.41% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | -16.25% | -99.56% | -48.75% | -32.00% |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 51.09% | 25.46% | 0.90% | -9.89% |
| Immunome, Inc. (IMNM)vs › | $2.02B | -48.43% | -97.59% | -126.46% | -100.04% |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 12.01% | -4.52% | -16.89% | -11.36% |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.05B | 16.36% | 13.19% | 3.41% | -4.94% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | -40.09% | 4.56% | -13.84% | -2.18% |
ROE
-180.0%
ROA
-11.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -179.99% |
| 2026-03-31 | -295.85% |
| 2025-12-31 | -216.86% |
| 2025-09-30 | -507.12% |
| 2025-06-30 | -388.86% |
| 2025-03-31 | -231.14% |
| 2024-12-31 | -159.33% |
| 2024-09-30 | -215.86% |
| 2024-06-30 | -184.81% |
| 2024-03-31 | -145.42% |
| 2023-12-31 | -426.76% |
| 2023-09-30 | -234.60% |
| 2023-06-30 | -110.91% |
| 2022-06-30 | -453.19% |
| 2022-03-31 | -83.88% |
| 2021-12-31 | -81.08% |
| 2021-09-30 | -52.94% |
| 2021-06-30 | -32.20% |
| 2021-03-31 | -37.64% |
| 2020-12-31 | -50.85% |
| 2020-09-30 | -47.57% |
| 2020-06-30 | -56.93% |
| 2020-03-31 | -49.97% |
| 2019-12-31 | -96.30% |
| 2019-09-30 | -98.41% |
| 2019-06-30 | -53.97% |
| 2019-03-31 | -41.53% |
| 2018-12-31 | -30.36% |
| 2018-09-30 | -23.01% |
